It is well established that the immune response decreases with aging. With this, we observe a moderate increase in circulating inflammatory mediators, known as “inflamm-aging”. However, the dynamics of the immune loss process, at the individual level, has not been… Continue Reading →
There is an urgent need to develop reliable and sensitive bloodbased biomarkers of Alzheimer’s disease (AD) that can be used for screening and to increase the efficiency of clinical trials. The European Union-North American Clinical Trials in Alzheimer’s Disease Task… Continue Reading →
Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →
© 2025 Aging-news